Cambridge’s Echion Technologies has carved a fresh edge in a multibillion dollar global battery market as partner CBMM ...
Cambridge biopharma company Microbiotica reveals that the first patient has been dosed in its Phase 1b First-in-Human trial, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback